Hi Gaygee,
The results of treatment with Revlimid (lenalidomide) are positive for many MDS patients especially for patients with the chromosome aberration 5q deletion. Here is a link about treatment results:
Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes.
It is common with adverse reactions like low red and white blood cells and low platelets initially:
Understanding Side Effects.
Kind regards
Birgitta-A
69 yo, dx MDS interm-1 May 2006, transfusion dependent, Desferal for iron overload, Neupogen for low white blood cells.